Skip to main content

Advertisement

SpringerLink
Log in

Targeted peripheral analgesics therapy for neuropathic pain

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

The term targeted peripheral analgesics has been suggested to describe analgesics with a mechanism of action that appears to be primarily through reducing pain transmission within the peripheral nervous system. Key differences between targeted peripheral (topical) and systemic analgesics and the difference between topical and transdermal analgesics are discussed in this article. A review of the clinical conditions, which have been reported to respond to targeted peripheral analgesics, also is described in detail.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Argoff CE: New analgesics for neuropathic pain: the lidocaine patch. Clin J Pain 2000, 16:S62-S65.

    PubMed  CAS  Google Scholar 

  2. Argoff CE: Targeted topical peripheral analgesics in the management of pain. Curr Pain Headache Rep 2002, 7:34–38. This review highlights the important uses of these types of analgesics in various types of painful conditions.

    Google Scholar 

  3. Galer BS: Topical medications. In Bonica’s Management of Pain. Edited by Loeser JD. Philadelphia: Lippincott Williams & Wilkins; 2001:1736–1741.

    Google Scholar 

  4. Gammaitoni AR, Alvarez NA: 24-Hour application of the lidocaine patch 5% for 3 consecutive days is safe and well tolerated in healthy adult men and women [Abstract PO6.20]. Presented at the 54th Annual American Academy of Neurology Meeting. Denver: April 13–20, 2002.

  5. Argoff C, Nicholson B, Moskowitz M, et al.: Effectiveness of lidocaine patch 5% (Lidoderm®) in the treatment of low back pain. Presented at the 10th World Congress on Pain. San Diego: August 17–22, 2002.

  6. Watson CP: Topical capsaicin as an adjuvant analgesic. J Pain Symptom Manage 1994, 9:425–433.

    Article  PubMed  CAS  Google Scholar 

  7. Gammaitoni AR, Davis MW: Pharmacokinetics and tolerability of lidocaine 5% patch with extended dosing. Ann Pharmacother 2002, 36:236–240.

    Article  PubMed  CAS  Google Scholar 

  8. Ness TJ, Jones L, Smith H: Use of compounded topical analgesics: results of an Internet survey. Reg Anesth Pain Med 2002, 27:309–312.

    Article  PubMed  Google Scholar 

  9. Sawynok J: Topical and peripherally acting analgesics. Pharmacol Rev 2003, 55:1–20. This fascinating review describes the numerous potential compounds that could possibly be used as topical or targeted peripheral analgesics, most of which have not been clinically developed.

    Article  PubMed  CAS  Google Scholar 

  10. Robbins W: Clinical applications of capsaicinoids. Clin J Pain 2000, 16:S86-S89.

    Article  PubMed  CAS  Google Scholar 

  11. Rowbotham MC: Topical analgesic agents. In Pharmacologic Approaches to the Treatment of Chronic Pain: New Concepts and Critical Issues. Edited by Fields HL, Liebeskind JC. Seattle: IASP Press; 1994:211–227.

    Google Scholar 

  12. Cashman JN: The mechanism of action of NSAIDs in analgesia. Drugs 1996, 52(suppl 5):13–23.

    PubMed  CAS  Google Scholar 

  13. Yesilyurt O, Dogrul A, Gul H, et al.: Topical cannabinoid enhances topical morphine antinociception. Pain 2003, 105:303–308. The use of topical cannabinoids as analgesics is a novel concept. This article demonstrates some of the properties of these agents, specifically their role in augmenting opiate effects in an experimental setting.

    Article  PubMed  CAS  Google Scholar 

  14. Sawynok J, Esser MJ, Reid AR: Antidepressants as analgesics: an overview of central and peripheral mechanisms of action. J Psychiatry Neurosci 2001, 26:21–29.

    PubMed  CAS  Google Scholar 

  15. Gerner P, Kao G, Srinivasa V, et al.: Topical amitriptyline in health volunteers. Reg Anesth Pain Med 2003, 28:289–293.

    Article  PubMed  CAS  Google Scholar 

  16. Physicians Desk Reference, edn 55. Montvale, NJ: Medical Economics Company; 2002.

  17. Rowbotham MC, Davies PS, Verkempinck, et al.: Lidocaine patch: double-blind, controlled study of a new treatment method for post-herpetic neuralgia. Pain 1996, 65:39–44.

    Article  PubMed  CAS  Google Scholar 

  18. Galer BS, Rowbotham MC, Perander J, et al.: Topical lidocaine patch relieves post-herpetic neuralgia more effectively than vehicle patch: results of an enriched enrollment study. Pain 1999, 80:533–538.

    Article  PubMed  CAS  Google Scholar 

  19. Katz NP, Davis MW, Dworkin RH: Topical lidocaine patch produces a significant improvement in mean pain scores and pain relief in treated PHN patients: results of a multicenter, open-label trial. J Pain 2001, 2:9–18.

    Google Scholar 

  20. Meier T, Wasner G, Faust M, et al.: Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 2003, 106:151–158. This study is important because it provides further evidence that a topical analgesic can be effective, in addition to PHN, for various other neuropathic pain states. It emphasizes that an analgesic working peripherally can be effective in reducing pain associated with active central nervous system processes.

    Article  PubMed  CAS  Google Scholar 

  21. Devers A, Galer BS: Topical lidocaine patch relieves a variety of neuropathic pain conditions: an open-label study. Clin J Pain 2000, 16:205–208.

    Article  PubMed  CAS  Google Scholar 

  22. Data on file. Endo Pharmaceuticals, Inc. Chadds Ford, PA.

  23. Hart-Gouleau S, Gammaitoni A, Galer BS, et al.: Open-label study of the effectiveness and safety of the lidocaine patch 5% (Lidoderm®) in patients with painful diabetic neuropathy. Presented at the 10th World Congress on Pain. San Diego: August 17–22, 2002.

  24. Galer BS, Jensen MP: Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology 1997, 48:332–338.

    PubMed  CAS  Google Scholar 

  25. Barbano RL, Herrmann DN, Hart-Gouleau S, et al.: Effectiveness, tolerability, and impact on quality of life of lidocaine patch 5% in diabetic polyneuropathy. Arch Neurol, in press.

  26. Galer BS, Jensen MP, Ma T, et al.: The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the Neuropathic Pain Scale. Clin J Pain 2002, 18:297–301.

    Article  PubMed  Google Scholar 

  27. Lycka BA, Watson CP, Nevin K, et al.: EMLA® cream for the treatment of pain caused by post-herpetic neuralgia: a double-blind, placebo-controlled study [Abstract]. In Proceedings of the Annual Meeting of the American Pain Society; 1996:A111.

  28. Attal N, Brasseur L, Chauvin M, et al.: Effects of single and repeated applications of a eutectic mixture of local anesthetics (EMLA®) cream on spontaneous and evoked pain in postherpetic neuralgia. Pain 1999, 81:203–209.

    Article  PubMed  CAS  Google Scholar 

  29. Litman SJ, Vitkun SA, Poppers PJ: Use of EMLA® cream in the treatment of post-herpetic neuralgia. J Clin Anesth 1996, 8:54–57.

    Article  PubMed  CAS  Google Scholar 

  30. Lynch ME, Clark AJ, Sawynok J: A pilot study examining topical amitriptyline, ketamine, and a combination of both in the treatment of neuropathic pain. Clin J Pain 2003, 19:323–328.

    Article  PubMed  CAS  Google Scholar 

  31. Quan D, Wellish M, Gilden DH: Topical ketamine treatment of postherpetic neuralgia. Neurology 2003, 60:1391–1392.

    PubMed  Google Scholar 

  32. Greenway FL, Frome BM, Engels TM, et al.: Temporary relief of post-herpetic neuralgia pain with topical geranium oil. Am J Med 2003, 115:586–587.

    Article  PubMed  Google Scholar 

  33. Rains C, Bryson HM: Topical capsaicin: a review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy, and osteoarthritis. Drugs Aging 1995, 7:317–328.

    Article  PubMed  CAS  Google Scholar 

  34. Robbins WR, Staats PS, Levine J, et al.: Treatment of intractable pain with topical large-dose capsaicin: preliminary report. Anesth Analg 1998, 86:579–583.

    Article  PubMed  CAS  Google Scholar 

  35. McCleane G: Topical application of doxepin hydrochloride, capsaicin, and a combination of both produces analgesia in chronic neuropathic pain: a randomized, double-blind, placebo-controlled study. Br J Clin Pharmacol 2000, 49:574–579.

    Article  PubMed  CAS  Google Scholar 

  36. Marten M: Efficacy and tolerability of a topical NSAID patch (local action transcutaneous flurbiprofen) and oral diclofenac in the treatment of soft-tissue rheumatism. Clin Rheumatol 1997, 16:25–31.

    Article  Google Scholar 

  37. Galer BS, Rowbotham MC, Perander J, et al.: Topical diclofenac patch significantly reduces pain associated with minor sports injuries: results of a randomized, double-blind, placebocontrolled, multicenter study. J Pain Symptom Manage 2000, 19:287–294.

    Article  PubMed  CAS  Google Scholar 

  38. Jenoure P, Segesser B, Luhti U, et al.: A trial with diclofenac HEP plaster as topical treatment in minor sports injuries. Drugs Exp Clin Res 1993, 19:125–131.

    PubMed  CAS  Google Scholar 

  39. Bruhlmann P, Michel BA: Topical diclofenac patch in patients with knee osteoarthritis: a randomized, double-blind, controlled clinical trial. Clin Exp Rheumatol 2003, 21:193–198.

    PubMed  CAS  Google Scholar 

  40. Campbell J, Dunn T: Evaluation of topical ibuprofen cream in the treatment of acute ankle sprains. J Accidental Emerg Med 1994, 11:178–182.

    CAS  Google Scholar 

  41. Airaksinen O, Venalainen J, Pietilainen T: Ketoprofen 2.5% gel versus placebo gel in the treatment of acute soft tissue injuries. Int J Clin Pharmacol Ther Toxicol 1993, 31:561–563.

    PubMed  CAS  Google Scholar 

  42. Machen J, Whitefield M: Efficacy of a proprietary ibuprofen gel in soft tissue injuries: a randomized, double-blind, placebo-controlled study. Intl J Clin Prac 2002, 56:102–106.

    CAS  Google Scholar 

  43. Whitefield M, O’Kane CJ, Anderson S: Comparative efficacy of a proprietary topical ibuprofen gel and oral ibuprofen in acute soft tissue injuries: a randomized, double-blind study. J Clin Pharm Ther 2002, 27:409–417.

    Article  PubMed  CAS  Google Scholar 

  44. Ottillinger B, Gomor B, Michel BA, et al.: Efficacy and safety of eltenac gel in the treatment of knee osteoarthritis. Osteoarthritis Cartilage 2001, 9:273–280.

    Article  PubMed  CAS  Google Scholar 

  45. Sandelin J, Harilainen A, Crone H, et al.: Local NSAID gel (eltenac) in the treatment of osteoarthritis of the knee: a double-blind study comparing eltenac with oral diclofenac and placebo gel. Scand J Rheumatol 1997, 26:287–292.

    Article  PubMed  CAS  Google Scholar 

  46. Dreiser RL, Tisne-Camus M: DHEP plasters as a topical treatment of knee osteoarthritis: a double-blind, placebocontrolled study. Drugs Exp Clin Res 1993, 19:107–115.

    Google Scholar 

  47. Galeazzi M, Marcolongo R: A placebo-controlled study of the efficacy and tolerability of a nonsteroidal anti-inflammatory drug, DHEP plaster in inflammatory peri- and extra-articular rheumatological diseases. Drugs Exp Clin Res 1993, 19:107–115.

    PubMed  CAS  Google Scholar 

  48. Gallachia G, Marcolongo R: Pharmacokinetics of diclofenac hydroxyethylpyrrolidine (DHEP) plasters in patients with monolateral knee joint effusion. Drugs Exp Clin Res 1993, 19:95–97.

    Google Scholar 

  49. Winocur E, Gavish A, Halachmi M, et al.: Topical application of capsaicin for the treatment of localized pain in the temporomandibular joint area. J Orofac Pain 2000, 14:31–36.

    PubMed  CAS  Google Scholar 

  50. Cohen M, Wolfe R, Mai T, et al.: A randomized, double-blind, placebo-controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol 2003, 30:523–528.

    PubMed  CAS  Google Scholar 

  51. Keitel W, Frerick H, Kuhn U, et al.: Capsicum pain plaster in chronic non-specific low back pain. Arzneimittelforschung 2001, 51:896–903.

    PubMed  CAS  Google Scholar 

  52. Lipman AG, Dalpiaz AS, London SP: Topical lidocaine patch therapy for myofascial pain [Abstract 782]. Presented at the Annual Scientific Meeting of the American Pain Society. Baltimore: March 14–17, 2002.

  53. Briggs M, Nelson EA: Topical agents or dressings for pain in venous leg ulcers. Cochrane Database Syst Rev 2003, (1):CD001177,

  54. Flock P: Pilot study to determine the effectiveness of diamorphine gel to control pressure ulcer pain. J Pain Symptom Manage 2003, 25:547–554.

    Article  PubMed  CAS  Google Scholar 

  55. Zeppetella G, Ribeiro PJ: Analgesic efficacy of morphine applied topically to painful ulcers. J Pain Symptom Manage 2003, 25:555–558.

    Article  PubMed  CAS  Google Scholar 

  56. Fassoulaki A, Sarantopoulos C, Melemeni A, et al.: EMLA reduces acute and chronic pain after breast surgery for cancer. Reg Anesth Pain Med 2000, 25:350–355.

    Article  PubMed  CAS  Google Scholar 

  57. Cerchietti LC, Navigante AH, Bonomi MR, et al.: Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002, 95:2230–2236.

    Article  PubMed  CAS  Google Scholar 

  58. Slatkin NE, Rhiner M: Topical ketamine in the treatment of mucositis pain. Pain Med 2003, 4:298–303.

    Article  PubMed  Google Scholar 

  59. Galeotti N, DeCesare Mannelli L, Mazzanti G, et al.: Menthol: a natural analgesic compound. Neurosci Lett 2002, 322:145–148.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. North Shore University Hospital/NYU School of Medicine, Cohn Pain Management Center, 4300 Hempstead Turnpike, 11714, Bethpage, NY, USA

    Charles E. Argoff MD

Authors
  1. Charles E. Argoff MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Argoff, C.E. Targeted peripheral analgesics therapy for neuropathic pain. Current Science Inc 8, 199–204 (2004). https://doi.org/10.1007/s11916-004-0052-6

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-004-0052-6

Keywords

Search

Navigation